10-Q Filing

Xenetic Biosciences, Inc. CIK: 1534525 Q2 2016

Filing Information

Form Type	10-Q
Accession Number	`0001019687-16-007260`
Period End Date	20160630
Filing Date	20160815
Fiscal Year	2016
Fiscal Period	Q2
XBRL Instance	xbio-20160630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 62 Income Statement 64 Cash Flow Statement 72

Balance Sheet 62 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Cash	`Cash`	$132.23K	USD	Point-in-time
Cash	`Cash`	$2.51M	USD	Point-in-time
Cash	`Cash`	$240.79K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.35M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	4.91M	shares	Point-in-time
Cash	`Cash`	$301.48K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	4.59M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.02M	shares	Point-in-time
Prepayment on acquisition	`PrepaymentOnAcquisition`	-	USD	Point-in-time
Prepayment on acquisition	`PrepaymentOnAcquisition`	$3.74M	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$171.20K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$247.30K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$478.50K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.19M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$58.47K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$62.02K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$129.31K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$97.24K	USD	Point-in-time
Total assets	`Assets`	$13.16M	USD	Point-in-time
Total assets	`Assets`	$16.91M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.79M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$2.02M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.61M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.49M	USD	Point-in-time
Hybrid debt instrument, net	`HybridDebtInstrument`	$3.65M	USD	Point-in-time
Hybrid debt instrument, net	`HybridDebtInstrument`	-	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$19.65K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$19.10K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$152.53K	USD	Point-in-time
Loans due to related parties	`DueToRelatedPartiesCurrent`	$395.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.34M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$38.79K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$29.45K	USD	Point-in-time
Total liabilities	`Liabilities`	$10.30M	USD	Point-in-time
Total liabilities	`Liabilities`	$6.75M	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of June 30, 2016 and December 31, 2015; 9,348,757 and 4,909,685 shares issued as of June 30, 2016 and December 31, 2015, respectively; 9,024,872 and 4,585,800 shares outstanding as of June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$9.35K	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of June 30, 2016 and December 31, 2015; 9,348,757 and 4,909,685 shares issued as of June 30, 2016 and December 31, 2015, respectively; 9,024,872 and 4,585,800 shares outstanding as of June 30, 2016 and December 31, 2015, respectively	`CommonStockValue`	$4.91K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$99.76M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$150.91M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-139.47M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-88.13M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$6.41M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$16.91M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$13.16M	USD	Point-in-time

Income Statement 64 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$2.21M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$555.74K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.59M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.63M	USD	2 Qtrs
IPR&D expense	`OtherResearchAndDevelopmentExpense`	$39.50M	USD	2 Qtrs
IPR&D expense	`OtherResearchAndDevelopmentExpense`	-	USD	1 Quarter
IPR&D expense	`OtherResearchAndDevelopmentExpense`	-	USD	2 Qtrs
IPR&D expense	`OtherResearchAndDevelopmentExpense`	$39.50M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.74M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$803.40K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.56M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.98M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-1.36M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-3.33M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-45.11M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-43.26M	USD	1 Quarter
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	$1.77M	USD	1 Quarter
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	$1.91M	USD	2 Qtrs
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	-	USD	1 Quarter
Change in fair value of derviative liability	`UnrealizedGainLossOnDerivatives`	-	USD	2 Qtrs
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	-	USD	2 Qtrs
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	-	USD	1 Quarter
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	-	USD	1 Quarter
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	$-1.58M	USD	2 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.19M	USD	1 Quarter
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.19M	USD	2 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-13.55K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-225.51K	USD	2 Qtrs
Other income (expense)	`OtherNonoperatingIncomeExpense`	$12.86K	USD	1 Quarter
Other income (expense)	`OtherNonoperatingIncomeExpense`	$234.45K	USD	1 Quarter
Interest income	`InterestIncomeOther`	$914.00	USD	1 Quarter
Interest income	`InterestIncomeOther`	$27.00	USD	2 Qtrs
Interest income	`InterestIncomeOther`	$13.00	USD	1 Quarter
Interest income	`InterestIncomeOther`	$1.09K	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.39K	USD	1 Quarter
Interest expense	`InterestExpense`	$103.09K	USD	1 Quarter
Interest expense	`InterestExpense`	$2.51K	USD	2 Qtrs
Interest expense	`InterestExpense`	$348.47K	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-6.23M	USD	2 Qtrs
Total other income (expense)	`NonoperatingIncomeExpense`	$-4.51M	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$233.98K	USD	1 Quarter
Total other income (expense)	`NonoperatingIncomeExpense`	$-226.94K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-3.56M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-51.34M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.77M	USD	1 Quarter
Other comprehensive loss from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	2 Qtrs
Other comprehensive loss from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	-	USD	1 Quarter
Other comprehensive loss from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-338.88K	USD	1 Quarter
Other comprehensive loss from foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-327.05K	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-3.88M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-47.77M	USD	1 Quarter
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-51.34M	USD	2 Qtrs
Total comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-1.46M	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-8.28	USD	2 Qtrs
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-6.12	USD	1 Quarter
Net loss per share of common stock, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.84	USD	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	6.20M	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.80M	shares	1 Quarter
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.22M	shares	2 Qtrs
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	4.22M	shares	1 Quarter

Cash Flow Statement 72 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.56M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.13M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-51.34M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-47.77M	USD	1 Quarter
IPR&D expense	`OtherResearchAndDevelopmentExpense`	$39.50M	USD	2 Qtrs
IPR&D expense	`OtherResearchAndDevelopmentExpense`	-	USD	1 Quarter
IPR&D expense	`OtherResearchAndDevelopmentExpense`	-	USD	2 Qtrs
IPR&D expense	`OtherResearchAndDevelopmentExpense`	$39.50M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.16K	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$38.83K	USD	2 Qtrs
Amortization of hybrid debt instrument discount	`AmortizationOfDebtDiscountPremium`	-	USD	2 Qtrs
Amortization of hybrid debt instrument discount	`AmortizationOfDebtDiscountPremium`	$204.00K	USD	2 Qtrs
Non-cash interest expense	`OtherNoncashExpense`	$142.93K	USD	2 Qtrs
Non-cash interest expense	`OtherNoncashExpense`	-	USD	2 Qtrs
Share-based payments	`ShareBasedCompensation`	$144.50K	USD	2 Qtrs
Share-based payments	`ShareBasedCompensation`	$899.62K	USD	2 Qtrs
Warrant expense for services	`FairValueAdjustmentOfWarrants`	$92.70K	USD	2 Qtrs
Warrant expense for services	`FairValueAdjustmentOfWarrants`	$1.12M	USD	2 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$1.77M	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	$1.91M	USD	2 Qtrs
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	1 Quarter
Change in fair value of derivative liability	`UnrealizedGainLossOnDerivatives`	-	USD	2 Qtrs
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	-	USD	2 Qtrs
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	-	USD	1 Quarter
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	-	USD	1 Quarter
Loss on issuance of hybrid debt instrument	`LossOnIssuanceOfHybridDebtInstrument`	$-1.58M	USD	2 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.19M	USD	1 Quarter
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	$-6.19M	USD	2 Qtrs
Loss on conversion of debt	`GainsLossesOnExtinguishmentOfDebt`	-	USD	2 Qtrs
Foreign currency translation	`ForeignCurrencyTransactionGainBeforeTax`	$-344.68K	USD	2 Qtrs
Foreign currency translation	`ForeignCurrencyTransactionGainBeforeTax`	-	USD	2 Qtrs
Other non-cash transactions	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	$129.33K	USD	2 Qtrs
Other non-cash transactions	`OtherSignificantNoncashTransactionValueOfConsiderationGiven1`	-	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-36.99K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-148.58K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$686.60K	USD	2 Qtrs
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$421.82K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-2.23M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.13M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$14.61K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.66K	USD	2 Qtrs
Disposition of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	2 Qtrs
Disposition of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$6.25K	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-14.61K	USD	2 Qtrs
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$4.58K	USD	2 Qtrs
Proceeds from issuance of promissory note	`ProceedsFromIssuanceOfDebt`	$3.50M	USD	2 Qtrs
Proceeds from issuance of promissory note	`ProceedsFromIssuanceOfDebt`	$100.00K	USD	2 Qtrs
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	-	USD	2 Qtrs
Payments on loan from related party	`RepaymentsOfRelatedPartyDebt`	$242.47K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$100.00K	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$3.26M	USD	2 Qtrs
Effect of exchange rate change on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	-	USD	2 Qtrs
Effect of exchange rate change on cash	`EffectOfExchangeRateOnCashAndCashEquivalents`	$-80.67K	USD	2 Qtrs
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$108.56K	USD	2 Qtrs
Net change in cash, excluding restricted cash	`CashPeriodIncreaseDecrease`	$-2.21M	USD	2 Qtrs
Cash at beginning of period	`Cash`	$132.23K	USD	Point-in-time
Cash at beginning of period	`Cash`	$2.51M	USD	Point-in-time
Cash at beginning of period	`Cash`	$240.79K	USD	Point-in-time
Cash at beginning of period	`Cash`	$301.48K	USD	Point-in-time
Cash at end of period	`Cash`	$132.23K	USD	Point-in-time
Cash at end of period	`Cash`	$2.51M	USD	Point-in-time
Cash at end of period	`Cash`	$240.79K	USD	Point-in-time
Cash at end of period	`Cash`	$301.48K	USD	Point-in-time
Convertible debt paid in common stock	`ConvertibleDebtPaidInCommonStock`	-	USD	2 Qtrs
Convertible debt paid in common stock	`ConvertibleDebtPaidInCommonStock`	$6.50M	USD	2 Qtrs
Interest paid in common stock	`SettlementOfAccruedInterestInCommonStock`	-	USD	2 Qtrs
Interest paid in common stock	`SettlementOfAccruedInterestInCommonStock`	$227.83K	USD	2 Qtrs
Non-cash issuance of warrants in connection with debt	`NoncashIssuanceOfWarrantsInConnectionWithDebt`	$1.70M	USD	2 Qtrs
Non-cash issuance of warrants in connection with debt	`NoncashIssuanceOfWarrantsInConnectionWithDebt`	-	USD	2 Qtrs
Non-cash recording of derivative liability in connection with debt	`NoncashRecordingOfDerivativeLiabilityInConnectionWithDebt`	$3.35M	USD	2 Qtrs
Non-cash recording of derivative liability in connection with debt	`NoncashRecordingOfDerivativeLiabilityInConnectionWithDebt`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.